# GENELUX Corp: filings

GNLX · Nasdaq · CIK 1231457 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/gnlx.md) · [Financials](/companies/gnlx/financials.md) · [Filings](/companies/gnlx/filings.md) · [Insiders](/companies/gnlx/insiders.md)

## Reports and events: 60 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 163, 144 35, 8-K 31, 3 19, 10-Q 11, CORRESP 9, UPLOAD 7, 424B5 6, S-1/A 6, S-8 6, 4/A 5, D 5, DEFA14A 5, 10-K 4, ARS 4, DEF 14A 4, FWP 4, EFFECT 3, SC 13G 3, 10-K/A 2, 144/A 2, DRS/A 2, DRSLTR 2, S-1 2, SCHEDULE 13G/A 2, SEC STAFF LETTER 2, 424B4 1, 8-A12B 1, CERT 1, DRS 1, S-3 1, SC 13G/A 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-13 | 13:05 ET | [10-Q](/filings/0001493152-26-037667.md) | Quarterly report, period 2026-06-30 | 0001493152-26-037667 |
| 2026-06-22 | 16:45 ET | [8-K](/filings/0001493152-26-029607.md) | 5.07 Shareholder vote results | 0001493152-26-029607 |
| 2026-05-07 | 16:07 ET | [10-Q](/filings/0001493152-26-021710.md) | Quarterly report, period 2026-03-31 | 0001493152-26-021710 |
| 2026-04-29 | 08:00 ET | [DEF 14A](/filings/0001493152-26-019473.md) | Proxy statement, period 2026-04-29 | 0001493152-26-019473 |
| 2026-03-19 | 16:52 ET | [8-K](/filings/0001493152-26-011649.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-011649 |
| 2026-03-19 | 16:05 ET | [10-K](/filings/0001493152-26-011616.md) | Annual report, period 2025-12-31 | 0001493152-26-011616 |
| 2026-02-02 | 16:16 ET | [8-K](/filings/0001493152-26-004755.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-004755 |
| 2026-01-08 | 17:09 ET | [8-K](/filings/0001493152-26-000989.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-000989 |
| 2026-01-05 | 08:15 ET | [8-K](/filings/0001493152-26-000270.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-000270 |
| 2026-01-02 | 16:10 ET | [8-K](/filings/0001493152-26-000115.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-000115 |
| 2025-11-05 | 16:06 ET | [10-Q](/filings/0001493152-25-020874.md) | Quarterly report, period 2025-09-30 | 0001493152-25-020874 |
| 2025-09-03 | 16:05 ET | [8-K](/filings/0001641172-25-026390.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001641172-25-026390 |
| 2025-08-07 | 16:07 ET | [10-Q](/filings/0001641172-25-022583.md) | Quarterly report, period 2025-06-30 | 0001641172-25-022583 |
| 2025-07-11 | 08:00 ET | [DEF 14A](/filings/0001641172-25-018673.md) | Proxy statement, period 2025-07-11 | 0001641172-25-018673 |
| 2025-05-06 | 16:06 ET | [10-Q](/filings/0001641172-25-008838.md) | Quarterly report, period 2025-03-31 | 0001641172-25-008838 |
| 2025-04-29 | 16:05 ET | [10-K/A](/filings/0001641172-25-006650.md) | Annual report, amended, period 2024-12-31 | 0001641172-25-006650 |
| 2025-03-28 | 16:05 ET | [10-K](/filings/0001641172-25-001184.md) | Annual report, period 2024-12-31 | 0001641172-25-001184 |
| 2025-03-25 | 17:27 ET | [8-K](/filings/0001641172-25-000642.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-000642 |
| 2025-03-25 | 09:03 ET | [8-K](/filings/0001641172-25-000528.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-000528 |
| 2025-02-03 | 06:08 ET | [8-K](/filings/0001493152-25-004554.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-25-004554 |
| 2024-11-14 | 16:01 ET | [10-Q](/filings/0001493152-24-045790.md) | Quarterly report, period 2024-09-30 | 0001493152-24-045790 |
| 2024-11-08 | 16:01 ET | [8-K](/filings/0001493152-24-044258.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-044258 |
| 2024-10-03 | 17:30 ET | [8-K](/filings/0001493152-24-039417.md) | 5.02 Departure or appointment of officers or directors | 0001493152-24-039417 |
| 2024-08-14 | 16:01 ET | [10-Q](/filings/0001493152-24-032145.md) | Quarterly report, period 2024-06-30 | 0001493152-24-032145 |
| 2024-08-06 | 16:02 ET | [8-K](/filings/0001493152-24-030410.md) | 5.07 Shareholder vote results | 0001493152-24-030410 |
| 2024-08-01 | 09:00 ET | [8-K](/filings/0001493152-24-029876.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-029876 |
| 2024-06-14 | 16:10 ET | [DEF 14A](/filings/0001493152-24-023868.md) | Proxy statement, period 2024-06-14 | 0001493152-24-023868 |
| 2024-06-05 | 21:58 ET | [8-K](/filings/0001493152-24-022621.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-022621 |
| 2024-05-24 | 08:11 ET | [8-K](/filings/0001493152-24-021265.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-021265 |
| 2024-05-09 | 16:15 ET | [10-Q](/filings/0001493152-24-018436.md) | Quarterly report, period 2024-03-31 | 0001493152-24-018436 |
| 2024-04-09 | 16:15 ET | [8-K](/filings/0001493152-24-014071.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-014071 |
| 2024-04-02 | 18:37 ET | [8-K](/filings/0001493152-24-012563.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-012563 |
| 2024-03-29 | 15:01 ET | [10-K](/filings/0001493152-24-011946.md) | Annual report, period 2023-12-31 | 0001493152-24-011946 |
| 2024-02-05 | 09:15 ET | [8-K](/filings/0001493152-24-004898.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-004898 |
| 2024-02-02 | 16:39 ET | [8-K](/filings/0001493152-24-004778.md) | 2.02 Results of operations; 8.01 Other events | 0001493152-24-004778 |
| 2023-12-12 | 08:00 ET | [8-K](/filings/0001493152-23-044487.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-044487 |
| 2023-11-24 | 13:14 ET | [8-K](/filings/0001493152-23-042634.md) | 5.02 Departure or appointment of officers or directors | 0001493152-23-042634 |
| 2023-11-14 | 16:24 ET | [10-Q](/filings/0001493152-23-041151.md) | Quarterly report, period 2023-09-30 | 0001493152-23-041151 |
| 2023-10-10 | 16:05 ET | [8-K](/filings/0001493152-23-036730.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-036730 |
| 2023-09-14 | 06:05 ET | [8-K](/filings/0001493152-23-032543.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001493152-23-032543 |
| 2023-08-28 | 06:55 ET | [8-K](/filings/0001493152-23-030295.md) | 5.02 Departure or appointment of officers or directors | 0001493152-23-030295 |
| 2023-08-14 | 06:32 ET | [10-Q](/filings/0001493152-23-027998.md) | Quarterly report, period 2023-06-30 | 0001493152-23-027998 |
| 2023-07-20 | 16:05 ET | [DEF 14A](/filings/0001493152-23-025087.md) | Proxy statement, period 2023-07-20 | 0001493152-23-025087 |
| 2023-07-19 | 21:41 ET | [8-K](/filings/0001493152-23-024868.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-024868 |
| 2023-07-14 | 16:05 ET | [8-K](/filings/0001493152-23-024590.md) | 3.01 Delisting notice; 5.02 Departure or appointment of officers or directors | 0001493152-23-024590 |
| 2023-06-28 | 20:07 ET | [S-1](/filings/0001493152-23-022665.md) | Registration statement | 0001493152-23-022665 |
| 2023-06-27 | 16:25 ET | [8-K](/filings/0001493152-23-022627.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-022627 |
| 2023-06-12 | 06:17 ET | [8-K](/filings/0001493152-23-020828.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-23-020828 |
| 2023-06-02 | 06:05 ET | [8-K](/filings/0001493152-23-019861.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-23-019861 |
| 2023-05-15 | 06:11 ET | [10-Q](/filings/0001493152-23-016832.md) | Quarterly report, period 2023-03-31 | 0001493152-23-016832 |

Page 1 of 2. [Older](/companies/gnlx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:10 ET. No prices; not investment advice.